Campus Advisory and Fall Restart Access the latest updates, FAQs, and resources for the Adelphi community on the global coronavirus pandemic. » Campus Restart Plans
Adelphi University Logo

Participate in Research Projects

Inviting African American Women who are 5 Year (or more) Survivors of Breast Cancer to take a confidential Survey for a chance to win ($100 Amazon Gift Cards) 

The Research Group on Disparities in Health (RGDH) within the Department of Health and Behavior Studies at Teachers College, Columbia University, in New York, New York is conducting a study to learn more about the quality of life for survivors of breast cancer, including possible factors related to that quality (i.e. current health status, social support, religiosity/spirituality, support from a partner/spouse, stress, depression, anxiety, ways of coping).

  • Participation in this survey is limited to the first 250 Black women who have survived breast cancer for 5 year or more
  • Completing the online survey takes about 20-25 minutes
  • Those who complete the survey will have a 3 in 250 chance of winning 1 of 3 $100 Amazon gift cards
  • Please click on the link below to view the informed consent, learn about your rights as a participant and proceed to the survey.
  • We also invite you to forward this information to other African American women who are survivors of breast cancer—or text message, or tweet the message, below:

GO TO to take the survey for Black Women survivors of breast cancer
(5 years +) on quality of life for chance to win 1 of 3 $100 Amazon gift cards

NOTE: Participants have a 3 in 250 chance of winning 1 of 3 $100 Amazon gift cards

If you have any questions or would like to have additional information about the study, please contact:

Elsy Mecklembourg, MPH, Doctoral Candidate, Department of Health and Behavior Studies, Teachers College, Columbia University, Box 114, 525 W. 120th Street, New York, NY 10027; –  OR –

Barbara C. Wallace, Ph.D., Director, Research Group on Disparities in Health, Professor of Health Education, Clinical Psychologist, Department of Health and Behavior Studies, Teachers College, Columbia University, Box 114, 525 W. 120th Street, New York, NY 10027;; Study Contact Number:  267-269-7411

Community Healthcare Survey

In order for Stony Brook Medicine to best serve the needs of the community, they would like to hear from you. This survey contains questions about challenges you may face regarding healthcare. The survey will only take about five minutes to complete. 

Your answers will provide insight on ways to improve patient care and procedures to more effectively address the needs of the community. 

If you would like to participate in this survey, please click here.

Study on Geriatric Assessment for Patients 70+:
Bridging the GAP to Improve Chemotherapy Toxicities
This study is being conducted to find out if a Geriatric Assessment (survey) can help improve and develop a standard approach for reducing side effects from chemotherapy in older patients with cancer.   

For more information about this study, please Click here to see the brochure.
If interested, speak with your doctor or contact Dr. Vincent Vinciguerra at
North Shore-LIJ Health System, Monter Cancer Center
450 Lakeville Road, Lake Success, NY 11042 • 516-734-8954

Research Participants Needed for Study of Early Onset Breast Cancer
A research study is being conducted at The Feinstein Institute for Medical Research, part of Northwell Health, to learn more about how genetic variants act and are influenced by other genes or environmental factors in the development of breast cancer before the age of 40 years. The researcher, Annette Lee, PhD is recruiting women with and without BRCA mutations who were diagnosed with early onset breast cancer to participate in this study.

For more information about this study, please Click here to see the brochure.
If interested, please contact the study nurse at 516-562-8377 or
Please watch this video which talks about the study and how you can participate.

Take the First Ever National Young Adult Cancer Survey!
In an unprecedented partnership, Stupid Cancer, Young Survival Coalition (YSC) and Critical Mass are teaming up for the first ever National Young Adult Cancer Survey. Please help us prioritize, in your opinion, the most pressing issues facing the young adult cancer movement today. Your insight will help us more effectively and efficiently channel our collaborative strategy.

Take the survey here:

Exciting New PET Scan Study for Breast Cancer
Patients need to be postmenopausal, have a recent diagnosis of breast cancer, have NOT yet had surgery, and to be naive to systemic therapies. The commitment is a single 8-9 hour day. A limo will drive the patient to and from the City (the Cornell PET facility on East 70th street or so) with door to door service. She will undergo 2 PET scans with radiolabelled vorozole (our aromatase inhibitor), before and after a dose of unlabelled oral letrozole (Femara).

Lunch is provided and she may bring a companion for the day. She receives $200 compensation for her time. If interested,
please call 631-632-6245. Click here to see the brochure.

A Phase I Study of the Safety and Tolerability of Single Agent MSI-1436C in Metastatic Breast Cancer Patients

Northwell Health in collaboration with Cold Spring Harbor Laboratory and DepYmed, inc. have a new clinical trial is available which involves an experimental drug that interferes with breast cancer growth. For more information, click here

Army of Women – Dr. Susan Love Research Foundation

Participate in this study to help us learn if this drup combination can prevent new brain metastases. 
This study is conducted by Alexandra Zimmer, M.D., National Cancer Institute, Bethesda, MD

WHAT IS THIS STUDY ABOUT: The purpose of this study is to investigate whether using Temodar and Kadcyla together decreases the chance of patients with HER2+ metastatic breast cancer developing new brain metastases. Approximately 18 participants wil take part in this study.

National Institutes of Health Clinical Center, Bethesda, MD

You can join the Phase I Study of T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery if you match ALL of these MAIN categories:

  • You are a woman or man with HER2+ metastatic breast cancer
  • You have brain metastases which were treated by stereotactic radiation or surgery within the last 3-6 weeks
  • You are able to complete a brain MRI, lumbar puncture, bloodwork, and provide a pre-enrollment brain tumor sample if available.
  • You live near or are able to travel to Bethesda, MD
Please click here for more information and to learn about this study.
Follow Adelphi NY Statewide Breast Cancer Program at:          

For further information, please contact:

Breast Cancer Hotline and Support Program
p – 516.877.4320
e –

Support Hotline: 800.877.8077